Dr. Phan is an accomplished Drug Discovery leader with more than 15 years of industry experience in building and leading research teams to discover and develop therapeutic agents in diverse areas of unmet medical need. Most recently, Dr. Phan served as the director of In Vivo Pharmacology at Ferring Pharmaceuticals where he and his team conducted preclinical research to support Ferring’s global pipeline. Previously, he held a position as Associate Director of Drug Discovery at Pfenex where he established the preclinical drug discovery infrastructure and co-developed an innovative rare disease and oncology strategy. Prior to Pfenex, he was a Senior Investigator at The Genomics Institute of the Novartis Research Foundation where he led drug discovery programs in Type 1 Diabetes and Heart Failure indications. Dr. Phan spent 10 years at Gilead Sciences in the Cardiovascular Therapeutic Area after his postdoctoral fellow training at the University of Texas, Southwestern Medical Center. During his tenure at Gilead Sciences as Senior Research Scientist, Dr. Phan and his team identified and validated numerous targets, initiated drug discovery programs and co-led a novel kinase inhibitor program into the clinic for Diabetic Kidney Disease and Pulmonary Arterial Hypertension. Dr. Phan earned his Ph.D. at the University of Texas, MD Anderson Cancer Center in Molecular Pathology and his B.S in Genetics from the University of California at Davis.